- Lobbying
- Lobbying by The National Cannabis Industry Association
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Michael Esposito | President |
Nick Tobenkin | Vice President |
Michael Stroud | Depty Chief Counsel, House Homeland Security Committee; Depty Assistant Secy Legislative Affairs, Dept of Homeland Security |
Kip Talley | Chief of Staff to Matt Gaetz |
Kevin Talley | Chief of Staff to Matt Gaetz Chief of Staff, Congressman Gaetz |
Christopher Carney | Member of Congress |
John Lopez | n/a |
Jim Kiley | n/a |
Michael Grimes | n/a |
Nicholas Tobenkin | n/a |
Benjamin Odendahl | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Q4 Report
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
U.S. House of Representatives
Justice - Dept of (DOJ)
Drug Enforcement Administration (DEA)
Food & Drug Administration (FDA)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
U.S. House of Representatives
Justice - Dept of (DOJ)
Drug Enforcement Administration (DEA)
Food & Drug Administration (FDA)
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
U.S. Senate
U.S. House of Representatives
Justice - Dept of (DOJ)
Drug Enforcement Administration (DEA)
Food & Drug Administration (FDA)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
U.S. House of Representatives
Justice - Dept of (DOJ)
Drug Enforcement Administration (DEA)
Food & Drug Administration (FDA)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
U.S. House of Representatives
Justice - Dept of (DOJ)
Drug Enforcement Administration (DEA)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
U.S. House of Representatives
Justice - Dept of (DOJ)
Drug Enforcement Administration (DEA)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
U.S. House of Representatives
Justice - Dept of (DOJ)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
U.S. House of Representatives
Justice - Dept of (DOJ)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
U.S. House of Representatives
Justice - Dept of (DOJ)
Type of Issue
Registration
Issue(s) they said they’d lobby about: Educating key decision makers on the state-legal cannabis business industry..
Q3 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate